JPRN-UMIN000004705已完成未知
Effect of cilostazol on in-stent restenosis after carotid artery stenting; Multi-center, prospective, randomized, open-label blind-endpoint trial - Carotid Artery Stenting with Cilostazol Addition for Restenosis (CAS-CARE)
Translational Research Informatics Canter0 个研究点目标入组 707 人开始时间: 2010年12月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 707
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Received endovascular interevention Scheduled for bilateral carotid intervention aortitis or cvasculitis congessive heart failure ischemic stroke within 48 hours hemorrhagic stroke within 90 days renal failure
研究者
相似试验
已完成
不适用
Carotid Artery Stenting With Cilostazol Addition for RestenosisIn-stent Restenosis After Carotid Artery StentingNCT01261234Kobe City General Hospital707
已完成
不适用
Cilostazol Reduces Restenosis Following Endovascular Therapy in Patients with Femoro-popliteal LesionsPatients who underwent endovascular therapy for symptomatic de novo FP lesionsJPRN-UMIN000001036Kansai Rosai Hospital127
尚未招募
不适用
A study to evaluate the effect of cilostazol after endovascular therapy for SFA lesionsPeripheral arterial diseaseJPRN-UMIN000011131Saiseikai yokohama city eastern hospital100
已完成
2 期
Impact of cilostazol on infrapopliteal angioplastyPeripheral arterial disease.Peripheral vascular disease, unspecifiedI73.9IRCT20190418043306N1Ahvaz University of Medical Sciences60
尚未招募
不适用
Effects of cilostazol on cerebral vasospasm after subarachnoid hemorrhagesubarachnoid hemorrhageJPRN-UMIN000011843Tokyo Women's Medical University Medical Center East Department of Neurosurgery200